Linked Data API

Show Search Form

Search Results

1002675
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when he plans to publish the decision on the future of the National Cancer Patient Experience Survey in relation to the National Data Guardian opt-out beyond 2018. more like this
star this property tabling member constituency Scunthorpe more like this
star this property tabling member printed
Nic Dakin more like this
star this property uin 188813 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-11-12more like thismore than 2018-11-12
unstar this property answer text <p>We are giving careful consideration to the application of the national data opt-out to the national cancer patient experience survey as stated in the Government’s response to the National Data Guardian Review July 2017 and other national patient experience surveys. This includes looking at the potential advantages and disadvantages of the national data opt-out not applying to these surveys beyond 2018/19.</p><p> </p><p>In spring 2018 we confirmed that for 2018/2019 the national data opt-out would not be applied to the national cancer patient experience survey and other patient experience surveys. A decision regarding application of the national data opt-out to these surveys beyond 2018/19 will be communicated in due course.</p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN 188814 more like this
star this property question first answered
less than 2018-11-12T15:40:43.827Zmore like thismore than 2018-11-12T15:40:43.827Z
star this property answering member
4065
star this property label Biography information for Dame Jackie Doyle-Price remove filter
star this property tabling member
4056
unstar this property label Biography information for Nic Dakin more like this
1002676
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cancer more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of enabling the National Cancer Patient Experience Survey to be exemption from the national data guardian opt out after 2018. more like this
star this property tabling member constituency Scunthorpe more like this
star this property tabling member printed
Nic Dakin more like this
star this property uin 188814 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-11-12more like thismore than 2018-11-12
unstar this property answer text <p>We are giving careful consideration to the application of the national data opt-out to the national cancer patient experience survey as stated in the Government’s response to the National Data Guardian Review July 2017 and other national patient experience surveys. This includes looking at the potential advantages and disadvantages of the national data opt-out not applying to these surveys beyond 2018/19.</p><p> </p><p>In spring 2018 we confirmed that for 2018/2019 the national data opt-out would not be applied to the national cancer patient experience survey and other patient experience surveys. A decision regarding application of the national data opt-out to these surveys beyond 2018/19 will be communicated in due course.</p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN 188813 more like this
star this property question first answered
less than 2018-11-12T15:40:43.883Zmore like thismore than 2018-11-12T15:40:43.883Z
star this property answering member
4065
star this property label Biography information for Dame Jackie Doyle-Price remove filter
star this property tabling member
4056
unstar this property label Biography information for Nic Dakin more like this
1002591
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether he plans to extend the expiration date of medicines to reduce waste; and if he will make a statement. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Dr David Drew more like this
star this property uin 188702 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-11-12more like thismore than 2018-11-12
unstar this property answer text <p>Any change to the expiry date of a medicine requires an independent review of the stability study by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicine Agency in consultation with the MHRA. The MHRA is the Government agency responsible for ensuring that medicines and medical devices work and are acceptably safe.</p><p> </p><p>Companies can and often do extend the shelf life of their medicines once the product is on the market and additional stability data become available. The MHRA is not able to insist on lengthy shelf lives considering the time needed to complete stability studies as to do so would create additional delays with bringing new medicines to the market. It is not possible however to extend the expiry date of all medicines unilaterally in the absence of supporting stability data.</p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2018-11-12T15:39:28.56Zmore like thismore than 2018-11-12T15:39:28.56Z
star this property answering member
4065
star this property label Biography information for Dame Jackie Doyle-Price remove filter
star this property tabling member
252
unstar this property label Biography information for Dr David Drew more like this
1002755
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Mental Health Services more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of changes in the level of funding for (a) Sure Start centres, (b) youth centres and (c) other universal services on trends in the level of demand for NHS mental health services. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger more like this
star this property uin 188806 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-11-12more like thismore than 2018-11-12
unstar this property answer text <p>No formal assessment has been made.</p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2018-11-12T15:38:19.757Zmore like thismore than 2018-11-12T15:38:19.757Z
star this property answering member
4065
star this property label Biography information for Dame Jackie Doyle-Price remove filter
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this